3Rosing J, Curvers J, Tans G. Oral contraceptives, thrombosis and haemostasis. [J] Eur J Obstet Gynecol Reprod Biol. 2001 Apr; 95 (2): 193-7.
4Kemmeren JM, , Meijers JC, etal. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial. [J] Blood. 2004 Sep 15; 104 (6): 1907; author reply 1908-9.
5果纳芬说明书.
6Jerome F, Strauss III, Robert L, et al . Yen & Jaffe 生殖内分泌学[M].第5版.北京:人民卫生出版社,2006.839-840.
7Kim HC, Kemmann E, Shelden RM and Saidi P (1981) Response of blood coagulation parameters to elevated endogenous 17 beta-estradiol levels induced by hulllan menopausal gonadotropins. Am J Obstet Gynecol 140, 807-810.
8Loret de Mola JR, Kiwi R, Austin C and Goldfarb JM .Subclavian deep vein thrombosis associated with the use of recombinant follicle-stimulating hormone (Gonal-F) complicat ing mi Id ovarian hyperst imulat ion syndrome. Ferti I Steril, 2000, 73: 1253-1256.
9G. Ricci, F. Cerneca, R. Simeone, etal. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial [J]. Hum Reprod ,2004,19(4): 838-848.
10Chan WS. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. [J]. Curr Opin Obstet Gynecol, 2009 Jun; 21(3) : 207-18.
